| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allogeneic Stem Cell Transplantation after Salvage Inotuzumab Ozogamicin: A Happy Ending?
|
Ai, Jing
|
|
2019
|
25 |
9 |
p. e273-e274
|
artikel
|
| 2 |
ASTCT Notes
|
|
|
2019
|
25 |
9 |
p. 1908-1909
|
artikel
|
| 3 |
Autologous Hematopoietic Stem Cell Transplantation in Acute Myelogenous Leukemia
|
Zhao, Yuanqi
|
|
2019
|
25 |
9 |
p. e285-e292
|
artikel
|
| 4 |
Autologous Stem Cell Transplantation for Multiple Myeloma: Growth Factor Matters
|
Chen, Jason
|
|
2019
|
25 |
9 |
p. e293-e297
|
artikel
|
| 5 |
Characterization of Viral Infections after Antithymocyte Globulin–Based Conditioning in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
|
Figgins, Bradley
|
|
2019
|
25 |
9 |
p. 1837-1843
|
artikel
|
| 6 |
Combination of the Centre for International Blood and Marrow Transplant Registry Risk Score and the Global Severity Score Enhances Prognostic Risk Stratification in Patients Receiving Frontline Therapy for Chronic Graft-versus-Host Disease
|
Shapiro, Roman M.
|
|
2019
|
25 |
9 |
p. 1761-1769
|
artikel
|
| 7 |
Dynamic Graft-versus-Host Disease-Free, Relapse-Free Survival: Multistate Modeling of the Morbidity and Mortality of Allotransplantation
|
Holtan, Shernan G.
|
|
2019
|
25 |
9 |
p. 1884-1889
|
artikel
|
| 8 |
Editorial Board
|
|
|
2019
|
25 |
9 |
p. A10
|
artikel
|
| 9 |
Feasibility and Safety of Treosulfan, Melphalan, and Thiotepa-Based Megachemotherapy with Autologous or Allogeneic Stem Cell Transplantation in Heavily Pretreated Children with Relapsed or Refractory Neuroblastoma
|
Wawrzyniak-Dzierżek, Elżbieta
|
|
2019
|
25 |
9 |
p. 1792-1797
|
artikel
|
| 10 |
Gonadal Function after Busulfan Compared with Treosulfan in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplant
|
Faraci, Maura
|
|
2019
|
25 |
9 |
p. 1786-1791
|
artikel
|
| 11 |
Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement
|
McCune, Jeannine S.
|
|
2019
|
25 |
9 |
p. 1890-1897
|
artikel
|
| 12 |
Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation
|
Saad, Ayman
|
|
2019
|
25 |
9 |
p. 1875-1883
|
artikel
|
| 13 |
Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
|
Zhao, Yanmin
|
|
2019
|
25 |
9 |
p. 1898-1907
|
artikel
|
| 14 |
Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation
|
Hamilton, Betty K.
|
|
2019
|
25 |
9 |
p. 1744-1755
|
artikel
|
| 15 |
Isolated Extramedullary Relapse as a Poor Predictor of Survival after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia
|
Sakellari, Ioanna
|
|
2019
|
25 |
9 |
p. 1756-1760
|
artikel
|
| 16 |
Low-Dose Cotrimoxazole Administered in Hematopoietic Stem Cell Transplant Recipients as Prophylaxis for Pneumocystis jirovecii Pneumonia Is Effective in Prevention of Infection due to Nocardia
|
Gkirkas, Konstantinos
|
|
2019
|
25 |
9 |
p. e298-e299
|
artikel
|
| 17 |
Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide–Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma
|
Ahmed, Sairah
|
|
2019
|
25 |
9 |
p. 1859-1868
|
artikel
|
| 18 |
Masthead (Purpose and Scope)
|
|
|
2019
|
25 |
9 |
p. A9
|
artikel
|
| 19 |
Noninfectious Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation
|
Balaguer-Rosello, Aitana
|
|
2019
|
25 |
9 |
p. 1818-1824
|
artikel
|
| 20 |
Officers and Directors of ASBMT
|
|
|
2019
|
25 |
9 |
p. A11
|
artikel
|
| 21 |
Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease
|
Martin, Paul J.
|
|
2019
|
25 |
9 |
p. 1869-1874
|
artikel
|
| 22 |
Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia
|
Marks, David I.
|
|
2019
|
25 |
9 |
p. 1720-1729
|
artikel
|
| 23 |
Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy
|
Prata, Pedro H.
|
|
2019
|
25 |
9 |
p. 1798-1802
|
artikel
|
| 24 |
Peripheral Blood Stem Cells versus Bone Marrow for T Cell–Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma
|
Mariotti, Jacopo
|
|
2019
|
25 |
9 |
p. 1810-1817
|
artikel
|
| 25 |
Quality Improvement Initiative to Reduce Nighttime Noise in a Transplantation and Cellular Therapy Unit
|
Badia, Priscila
|
|
2019
|
25 |
9 |
p. 1844-1850
|
artikel
|
| 26 |
Recipe for a Graft: T Cell Dose Remains Elusive
|
Maziarz, Richard T.
|
|
2019
|
25 |
9 |
p. e275-e276
|
artikel
|
| 27 |
Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life
|
Kurosawa, Saiko
|
|
2019
|
25 |
9 |
p. 1851-1858
|
artikel
|
| 28 |
Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma
|
López-Corral, Lucia
|
|
2019
|
25 |
9 |
p. 1703-1712
|
artikel
|
| 29 |
Results of the First Clinical Study in Humans That Combines Hyperbaric Oxygen Pretreatment with Autologous Peripheral Blood Stem Cell Transplantation
|
Abdelhakim, Haitham
|
|
2019
|
25 |
9 |
p. 1713-1719
|
artikel
|
| 30 |
Risk Stratification and Prognosticators of Acute Myeloid Leukemia with Myelodysplasia-Related Changes in Patients Undergoing Allogeneic Stem Cell Transplantation: A Retrospective Study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation
|
Harada, Kaito
|
|
2019
|
25 |
9 |
p. 1730-1743
|
artikel
|
| 31 |
Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting
|
Nilsson, Christer
|
|
2019
|
25 |
9 |
p. 1770-1778
|
artikel
|
| 32 |
Table of Contents
|
|
|
2019
|
25 |
9 |
p. A17-A23
|
artikel
|
| 33 |
The Case for Upfront HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation as a Curative Option for Adult Acquired Severe Aplastic Anemia
|
Marsh, Judith C.W.
|
|
2019
|
25 |
9 |
p. e277-e284
|
artikel
|
| 34 |
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell–Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients
|
Pagliardini, Thomas
|
|
2019
|
25 |
9 |
p. 1803-1809
|
artikel
|
| 35 |
Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant
|
Bento, Leyre
|
|
2019
|
25 |
9 |
p. 1825-1831
|
artikel
|
| 36 |
Transplant Energize Me Patient Outcome (TEMPO): A Quality Improvement Project that Maintains Functional Mobility in Pediatric Patients Admitted for Allogeneic Hematopoietic Cell Transplantation
|
Gonzales, Anne
|
|
2019
|
25 |
9 |
p. 1779-1785
|
artikel
|
| 37 |
Use of Leflunomide for Treatment of Cytomegalovirus Infection in Recipients of Allogeneic Stem Cell Transplant
|
Gokarn, Anant
|
|
2019
|
25 |
9 |
p. 1832-1836
|
artikel
|
Tijdschrift beschrijving